Charles Schwab Investment Management Inc Longboard Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Longboard Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 67,641 shares of LBPH stock, worth $2.08 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,641
Previous 42,933
57.55%
Holding current value
$2.08 Million
Previous $258,000
466.28%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LBPH
# of Institutions
106Shares Held
30MCall Options Held
16.3KPut Options Held
56.5K-
Cormorant Asset Management, LP Boston, MA3.35MShares$103 Million4.17% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.94MShares$90.4 Million0.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.22MShares$68.2 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.14MShares$65.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.87MShares$57.4 Million0.0% of portfolio
About Longboard Pharmaceuticals, Inc.
- Ticker LBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,586,000
- Market Cap $418M
- Description
- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...